C3 and bacterial infectious disease: Despite their promise, long-term systemic C3 inhibition may impair host defense mechanisms, particularly increasing susceptibility to encapsulated bacterial infections such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae.